Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 2.430 | ||
| Révision: | $521.25M | $688.61M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.890 | 5.050 | 0.1600 |
| Révision: | $608.90M | $637.15M | $40.54M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.800 | 3.110 | -1.6900 |
| Révision: | $587.25M | $561.64M | -$17.39M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.430 | 4.940 | 0.5100 |
| Révision: | $588.20M | $544.62M | — |
